Capital Insight Partners, LLC Dexcom Inc Transaction History
Capital Insight Partners, LLC
- $524 Million
- Q2 2024
A detailed history of Capital Insight Partners, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Capital Insight Partners, LLC holds 3,690 shares of DXCM stock, worth $247,303. This represents 0.08% of its overall portfolio holdings.
Number of Shares
3,690
Previous 3,600
2.5%
Holding current value
$247,303
Previous $499,000
16.23%
% of portfolio
0.08%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding DXCM
# of Institutions
1,113Shares Held
365MCall Options Held
4.1MPut Options Held
3.65M-
Vanguard Group Inc Valley Forge, PA46.5MShares$3.12 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$2.31 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.3MShares$1.09 Billion0.08% of portfolio
-
Baillie Gifford & CO15.3MShares$1.03 Billion1.38% of portfolio
-
Capital Research Global Investors Los Angeles, CA11.9MShares$801 Million0.31% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $25.9B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...